Seifem Surveillance of Antifungal Combination Therapy In Hematologic Italian Centers (SEIFEM COMBO)

This study has been completed.
Sponsor:
Collaborator:
Catholic University of the Sacred Heart
Information provided by:
University Hospital, Udine, Italy
ClinicalTrials.gov Identifier:
NCT00906633
First received: May 19, 2009
Last updated: January 25, 2010
Last verified: May 2009
  Purpose

This trial is an observational study about combination antifungal therapy in hematologic patients with proven and probable invasive fungal infections (IFI).


Condition
Fungal Infection

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Seifem Observational Study of Antifungal Combination Therapy In Hematologic Italian Centers

Resource links provided by NLM:


Further study details as provided by University Hospital, Udine, Italy:

Primary Outcome Measures:
  • safety, efficacy and duration of therapy [ Time Frame: one year ] [ Designated as safety issue: No ]

Estimated Enrollment: 80
Study Start Date: January 2009
Study Completion Date: January 2010
Primary Completion Date: December 2009 (Final data collection date for primary outcome measure)
Groups/Cohorts
Outcome of combination antifungal therapy

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Haematologic patients with proven or probable invasive fungal infectious

Criteria

Inclusion Criteria:

  • Haematologic patients with proven or probable IFI
  • Therapy with a combination of antifungal drugs

Exclusion Criteria:

  • Haematologic patients with possible IFI
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00906633

Locations
Italy
University Hospital, Udine
Udine, Italy, 33100
Sponsors and Collaborators
University Hospital, Udine, Italy
Catholic University of the Sacred Heart
Investigators
Principal Investigator: ANNA CANDONI, MD University Hospital, Udine, Italy
  More Information

No publications provided

Responsible Party: CANDONI ANNA, UNIVERSITY HOSPITAL, Udine, Italy
ClinicalTrials.gov Identifier: NCT00906633     History of Changes
Other Study ID Numbers: SEIFEMcombo0509
Study First Received: May 19, 2009
Last Updated: January 25, 2010
Health Authority: Italy: Ethics Committee

Keywords provided by University Hospital, Udine, Italy:
antifungal therapies

Additional relevant MeSH terms:
Mycoses
Antifungal Agents
Clotrimazole
Miconazole
Anti-Infective Agents
Therapeutic Uses
Pharmacologic Actions
Anti-Infective Agents, Local
14-alpha Demethylase Inhibitors
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action

ClinicalTrials.gov processed this record on April 17, 2014